Comprehensive cytogenetic characterization of an esthesioneuroblastoma

Cancer Genetics and Cytogenetics

Volumn 173, Issue 2, 2007, Pages 89-96

  Holland, Heidrun ^a   Koschny, Ronald ^b,c   Krupp, Wolfgang ^d   Meixensberger, Jürgen ^d   Bauer, Manfred ^d   Kirsten, Holger ^a   Ahnert, Peter ^a  

^a Faculty of Medicine   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRYPSIN;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CHROMOSOME 13Q; CHROMOSOME 17; CHROMOSOME 17Q; CHROMOSOME 19; CHROMOSOME 21Q; CHROMOSOME 22; CHROMOSOME 22Q; CHROMOSOME 2Q; CHROMOSOME 5; CHROMOSOME 6Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME IDENTIFICATION; CHROMOSOME MOSAICISM; CHROMOSOME NUMBER; CYTOGENETICS; DNA MICROARRAY; ESTHESIONEUROBLASTOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FREQUENCY; GENE LOCUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPING; MALE; METAPHASE CHROMOSOME; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE CARE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STAINING; SURGICAL APPROACH; TRISOMY 8;

ADULT; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CYTOGENETIC ANALYSIS; ESTHESIONEUROBLASTOMA, OLFACTORY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; NASAL CAVITY; NOSE NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR CELLS, CULTURED;

EID: 33847098291     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.09.024     Document Type: Article

References (37)

1. Diaz Jr. E.M., Johnigan III R.H., Pero C., El-Naggar A.K., Roberts D.B., Barker J.L., and DeMonte F. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck 27 (2005) 138-149
2. Bradley P.J., Jones N.S., and Robertson I. Diagnosis and management of esthesioneuroblastoma. Curr Opin Otolaryngol Head Neck Surg 11 (2003) 112-118
3. Kleihues P., and Cavenee W.K. Pathology and genetics of tumours of the nervous system (1997), International Agency for Research on Cancer, Lyon
4. Morita A., Ebersold M.J., Olsen K.D., Foote R.L., Lewis J.E., and Quast L.M. Esthesioneuroblastoma: prognosis and management. Neurosurgery 32 (1993) 706-714 (Discussion 714-5)
5. Dulguerov P., Allal A.S., and Calcaterra T.C. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2 (2001) 683-690
6. Seitz S., Korsching E., Weimer J., Jacobsen A., Arnold N., Meindl A., Arnold W., Gustavus D., Klebig C., Petersen I., and Scherneck S. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8-mediated breast tumor suppression. Genes Chromosomes Cancer 45 (2006) 612-627
7. Cavazzana A.O., Navarro S., Noguera R., Reynolds P.C., and Triche T.J. Olfactory neuroblastoma is not a neuroblastoma but is related to primitive neuroectodermal tumor (PNET). Prog Clin Biol Res 271 (1988) 463-473
8. Delattre O., Zucman J., Melot T., Garau X.S., Zucker J.M., Lenoi G.M., Ambros P.F., Sheer D., Turc-Carel C., and Triche T.J. The Ewing family of tumors-a subgroup of small-round cell tumors defined by specific chimeric transcripts. N Engl J Med 331 (1994) 294-299
9. Sorensen P.H., Wu J.K., Berean K.W., Lim J.F., Donn W., Frierson H.F., Reynolds C.P., Lopez-Terrada D., and Triche T.J. Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma. Proc Natl Acad Sci USA 93 (1996) 1038-1043
10. Spiro J.D., Soo K.C., and Spiro R.H. Nonsquamous cell malignant neoplasms of the nasal cavities and paranasal sinuses. Head Neck 17 (1995) 114-118
11. Whang-Peng J., Freter C.E., Knutsen T., Nanfro J.J., and Gazdar A. Translocation t(11;22) in esthesioneuroblastoma. Cancer Genet Cytogenet 29 (1987) 155-157
12. Bockmuehl U., You X., Pacyna-Gengelbach M., Arps H., Draf W., and Petersen I. CGH Pattern of esthesioneuroblastoma and their metastases. Brain Pathol 14 (2004) 158-163
13. Sandberg A.A., and Bridge J.A. Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors. Cancer Genet Cytogenet 123 (2000) 1-26
14. Slater H.R., Bailey D.K., Ren H., Cao M., Bell K., Nasioulas S., Henke R., Choo K.H.A., and Kennedy G.C. High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs. Am J Hum Genet 77 (2005) 709-726
15. Van Devanter D.R., George D., McNutt M.A., Vogel A., and Luthardt F. Trisomy 8 in primary esthesioneuroblastoma. Cancer Genet Cytogenet 57 (1991) 133-136
16. Jin Y., Mertens F., Arheden K., Mandahl N., Wennerberg J., Dictor M., Heim S., and Mitelman F. Karyotypic features of malignant tumors of the nasal cavity and paranasal sinuses. Int J Cancer 60 (1995) 637-641
17. Riazimand S.H., Brieger J., Jacob R., Welkoborsky H.J., and Mann W.J. Analysis of cytogenetic aberrations in esthesioneuroblastoma by comparative genomic hybridization. Cancer Genet Cytogenet 136 (2002) 53-57
18. Szymas J., Wolf G., Kowalczyk D., Nowak S., and Petersen I. Olfactory neuroblastoma: detection of genomic imbalances by comparative genomic hybridization. Cancer Genet Cytogenet 139 (1997) 839-844
19. Mezzelani A., Tornielli S., Minoletti F., Pierotti M.A., Sozzi G., and Pilotti S. Esthesioneuroblastoma is not a member of the primitive peripheral neuroectodermal tumour-Ewing's group. Br J Cancer 81 (1999) 586-591
20. Dulgerov P., and Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 102 (1992) 843-849
21. Swansbury J. Cancer Cytogenetics, Methods and Protocols (2003), Humana Press, Totowa, NJ
22. Seabright M. A rapid banding technique for human chromosomes. Lancet 2 (1971) 971-972
23. Sambrook J., and Russell D.W. Molecular Cloning. A Laboratory Manual (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
24. Kennedy G.C., Matsuzaki H., Dong S., Liu W.M., Huang J., Liu G., Su X., Cao M., Chen W., Zhang J., Liu W., Yang G., Di X., Ryder T., He Z., Surti U., Ohillips M.S., Boyce-Jacino M.T., Fodor S.P., and Jones K.W. Large-scale genotyping of complex DNA. Nat Biotechnol 23 (2003) 1233-1237
25. Huang J., Wei W., Zhang J., Liu G., Bignell G.R., Stratton M.R., Futreal P.A., Wooster R., Jones K.W., and Shapero M.H. Whole genome DNA copy number changes identified by high density oligonucleotide arrays. Hum Genomics 1 (2004) 287-299
26. Futreal P.A., Coin L., Marshall M., Down T., Hubbard T., Wooster R., Rahman N., and Stratton M.R. A census of human cancer genes. Nat Rev Cancer 4 (2004) 177-183
27. Kumar S., Perlman E., Pack S., Davis M., Zhang H., Meltzer P., and Tsokos M. Absence of EWS/FLI1 fusion in olfactory neuroblastomas indicates these tumors do not belong to the Ewing's sarcoma family. Hum Pathol 30 (1999) 1356-1360
28. Heim S, Mitelman F. Cancer cytogenetics chromosomal and molecular genetic aberrations of tumor cells. New York: Alan R. Liss, Inc., pp. 494-5.
29. Sreekantaiah C., Ladanyi N., Rodriguez E., and Chaganti R.S.K. Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanism. Am J Pathol 144 (1994) 1121-1133
30. Travis J.A., and Bridge J.A. Significance of both numerical and structural chromosomal abnormalities in clear cell sarcoma. Cancer Genet Cytogenet 64 (1992) 104-106
31. Shlomit R., Ayala A.G., Michal D., Ninett A., Frida S., Boleslaw G., Gad B., Gideon R., and Shlomi C. Gains and losses of DNA sequences in childhood brain tumors analyzed by comparative genomic hybridization. Cancer Genet Cytogenet 121 (2000) 67-72
32. Dal Cin P., Sciot R., Aly M.S., Delabie J., Stas M., De Wever I., Van Damme B., and Van den Berghe H. Some desmoid tumors are characterized by trisomy 8. Genes Chromosomes Cancer 10 (1994) 131-135
33. Mitelman F. Human Chromosome Abnormalities: Catalogues and Collections. New York: Alan R. Liss, Inc., pp. 203-48.
34. Somers K.D., Winters B.A., Dawson D.M., Leffell M.S., Wright G.L., Devine C.J., Gilbert D.A., and Horton C.E. Chromosome abnormalities in Peyronie's disease. J Urol 37 (1987) 672-675
35. Stilgenbauer S., Bullinger L., Benner A., Wildenberger K., Bentz M., Döhner K., Ho A.D., Lichter P., and Döhner H. Incidence and clinical significance of 6q deletions in B cell chronic lymphotic leukemia. Leukemia 13 (1999) 1331-1334
36. Fink S.R., Paternoster S.F., Smoley S.A., Flynn H.C., Geyer S.M., Shanafelt T.D., Lee Y.K., Jelinek D.F., Kay N.E., and Dewald G.W. Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia. Leukemia Research 29 (2005) 253-262
37. Greco C., Alvino S., Buglioni S., Assisi D., Lapenta R., Grassi A., Stigliano V., Mottolese M., and Casale V. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression. Anticancer Res 21 (2001) 3185-3192